UPDATE: Lilly halts work on potential blockbuster cholesterol drug
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Health Care & Life Sciences
Articles
Lilly expands China drug partnership in growing cancer market
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
Eskenazi launches $50M effort to take brain care around the world
The safety-net hospital system in Indianapolis will create the Center for Brain Care Innovation and try to use telemedicine and a digital avatar to reach as many as 150,000 Hoosiers and 10 million patients outside Indiana by 2030.
Spiking drug prices punch holes in health insurers’ finances
Spending on prescription drugs has soared 451 percent this year at Indianapolis-based MDwise as new drugs for hepatitis C and cancer soar above $100,000 per patient.
Go figure: As patients’ anger over costs spikes, health care prices barely budge
Patients’ anger over high deductibles and high drug prices is spurring presidential candidates to respond—even as the actual prices of health care services are growing slower than at any time since 1990.
Hospital CEO: Telehealth could dampen future health care construction
Bryan Mills, CEO of the Community Health Network hospital system, said a recent pickup in health care construction could slow down if providers can successfully care for patients remotely via the Internet and phones.
American Senior fires No. 2 executive in wake of FBI raid
American Senior Communities has fired its chief operating officer and accepted the resignation of its chief financial officer—17 days after an FBI raid of its offices and the home of its former CEO James Burkhart.
The Anthem-Cigna Marriage: A Love Story in Three Acts
A 22-page timeline of events leading up to the $54 billion merger agreement between Anthem and Cigna shows that company executives fell in love early, but the Anthem board made them break up and they chased other lovers. But in the end, they were each other’s only choice.
Puerto Rico plans new corporate tax to replace excise levy
Puerto Rico officials are looking to replace an expiring tax with a new levy to draw much-needed revenue from the world’s best-selling medications while seeking to avoid driving U.S. manufacturers such as Eli Lilly and Co. from the commonwealth.
IU to receive up to $46M for effort to boost patient care
The university will lead a consortium of eight institutions that will use the money to create a system of coaches embedded in medical practices.
Lilly stock climbs on positive arthritis drug test
A potential rheumatoid arthritis treatment from drugmakers Eli Lilly and Co. and Incyte Corp. fared better than another drug in late-stage testing, Lilly said Tuesday.
Anthem says industry flush with competition, but local experts have doubts
After Anthem CEO Joe Swedish argued that his $54 billion purchase of Cigna Corp. wouldn’t harm competition, execs at some of Indiana’s most prominent health care and health insurance institutions expressed skepticism last week during the IBJ Health Care Power Breakfast.
Settlement clears way for Lilly to launch once-a-day insulin
The settlement with France-based Sanofi SA clears up uncertainty over a drug that could rack up more than $1 billion in sales by 2020, according to Wall Street analysts.
GOP wanted consumer-driven health care; Obamacare made it happen.
Since President Obama’s health law passed in 2010, deductibles on employer health plans have risen nearly seven times faster than wages and nearly three times faster than premiums, leaving consumers exposed more than ever to the sky-high cost of care.
Applications to Marian medical school keep rising
With the number of applications to Marian’s College of Osteopathic Medicine running twice as high as initially expected, school leaders say they are confident Marian can help reduce a looming physician shortage in Indiana.
Ball State trustees approve formation of College of Health
The new college's academic programs would include athletic training, nursing, speech pathology and psychology.
Clinton promises health insurance merger scrutiny in plan
Hillary Clinton said she would give close scrutiny to health-insurance industry mergers like those proposed this year by Anthem Inc. and Aetna Inc., part of the Democratic presidential candidate’s latest policy plans.
Purdue’s Chao Center regains drug, slashes $360-per-pill price
An Indiana not-for-profit has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90 percent after re-acquiring rights to the medicine from Rodelis Therapeutics.
Anthem, Aetna defend acquisitions called harmful by hospitals
Anthem Inc. CEO Joseph Swedish and Aetna Inc. CEO Mark Bertolini will tell federal lawmakers Tuesday that the deals are necessary to succeed in a changing health-care landscape.
Analyst: Lilly’s Jardiance diabetes pill could be a $6 billion-a-year blockbuster
It looks like Eli Lilly and Co. finally has a drug that can replace its former stars Zyprexa and Cymbalta. The most bullish analysts think Jardiance can surpass those $5 billion-a-year blockbusters.